Updated Jul 16, 2026
Smith Kevin P. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Kevin P. Smith is an executive at Inogen Inc, serving as Executive Vice President of Business Development and General Counsel. He has been involved in the medical technology sector, particularly in the development of portable oxygen concentrators.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-03 | INGN | Inogen Inc | F — Tax withholding / forfeiture | 6.3K | $6.10 | $38K |
| 2026-03-03 | INGN | Inogen Inc | M — Option exercise | 14.0K | $0.00 | |
| 2026-03-03 | INGN | Inogen Inc | A — Grant or award | 1.5K | $6.10 | $9K |
| 2025-09-01 | INGN | Inogen Inc | F — Tax withholding / forfeiture | 8.0K | $7.99 | $64K |
| 2025-09-01 | INGN | Inogen Inc | M — Option exercise | 18.1K | $0.00 | |
| 2025-09-01 | INGN | Inogen Inc | A — Grant or award | 1.5K | $7.99 | $12K |
Kevin P. Smith is an executive at Inogen Inc, serving as Executive Vice President of Business Development and General Counsel. He has been involved in the medical technology sector, particularly in the development of portable oxygen concentrators.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Smith Kevin P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.